XEL
58
3
WEC
48
2
NFLX
59
-2
STX
50
5
CINF
53
2
MDT
60
4
WRK
75
2
EQT
57
3
MKC
44
2
EMN
76
4
UAL
56
2
LLY
60
-7
TAP
45
-5
GD
66
2
EIX
58
2
CTSH
44
2
MMM
32
2
CCI
38
2
INTU
69
4
WBA
28
4
XEL
58
3
WEC
48
2
NFLX
59
-2
STX
50
5
CINF
53
2
MDT
60
4
WRK
75
2
EQT
57
3
MKC
44
2
EMN
76
4
UAL
56
2
LLY
60
-7
TAP
45
-5
GD
66
2
EIX
58
2
CTSH
44
2
MMM
32
2
CCI
38
2
INTU
69
4
WBA
28
4
Financhill
Back

Addex Therapeutics 10K Form

Sell
8

ADXN
Addex Therapeutics

Last Price:
8.60
Seasonality Move:
-21.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADXN News And Ratings

See the #1 stock for the next 7 days that we like better than ADXN

ADXN Financial Statistics

Sales & Book Value

Annual Sales: $1.8M
Cash Flow: $-557.5K
Price / Cash Flow: 0
Annual Sales: $1.31
Price / Book: 7.01

Profitability

EPS (TTM): -18.66180
Net Income (TTM): $-11.76M
Gross Margin: $2.55M
Return on Equity: -264.41%
Return on Assets: -150.19%

Addex Therapeutics Earnings Forecast

Key Addex Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 8 years for ADXN is 91.70%.
  • The Selling, General & Administrative Expenses for ADXN have been equal to 446.69% of Gross Profit Margin.
  • The Research & Development expenses have been 170.40% of Revenue.
  • The Interest Expense is -0.20% of Operating Income.
  • The Net Earning history of ADXN is -654.47% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 13 years.

Addex Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADXN
Website: addextherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.46
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADXN Technical Analysis vs Fundamental Analysis

Sell
8
Addex Therapeutics (ADXN) is a Sell

Is Addex Therapeutics a Buy or a Sell?